المؤلفون: V. V. Salukhov, E. V. Kryukov, M. A. Kharitonov, V. P. Sereda, A. A. Minakov

المصدر: Медицинский совет, Vol 0, Iss 16, Pp 174-184 (2021)

مصطلحات موضوعية: chronic obstructive pulmonary disease (copd), diagnosis, treatment, double bronchodilation, inhaled corticosteroids, triple therapy, Medicine

وصف الملف: electronic resource

Relation: https://www.med-sovet.pro/jour/article/view/6476; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790

URL الوصول: https://doaj.org/article/d880aabeb9cf4b41864cf0f0ca690b03

المؤلفون: D. L. Brovin, D. V. Kuleshova, O. F. Dementeva, K. N. Malikov, D. A. Dolgushev, V. P. Sereda, Д. Л. Бровин, Д. В. Кулешова, О. Ф. Дементьева, К. Н. Маликов, Д. А. Долгушев, В. П. Середа

المصدر: Meditsinskiy sovet = Medical Council; № 18 (2023); 160-165 ; Медицинский Совет; № 18 (2023); 160-165 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: колоноскопия, aortic valve, E. coli, bacterial translocation, laxatives, colonoscopy, аортальный клапан, бактериальная транслокация, слабительные средства

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7859/6980; Zheng D, Zhou H, Wang H, Zhu Y, Wu Y, Li Q, Li T, Liu L. Mesenchymal stem cell-derived microvesicles improve intestinal barrier function by restoring mitochondrial dynamic balance in sepsis rats. Stem Cell Res Ther. 2021;12(1):299. https://doi.org/10.1186/s13287-021-02363-0.; Assimakopoulos SF, Triantos C, Thomopoulos K, Fligou F, Maroulis I, Marangos M, Gogos CA. Gut-origin sepsis in the critically ill patient: pathophysiology and treatment. Infection. 2018;46(6):751–760. https://doi.org/10.1007/s15010-018-1178-5.; Vaishnavi C. Translocation of gut flora and its role in sepsis. Indian J Med Microbiol. 2013;31(4):334–342. https://doi.org/10.4103/0255-0857.118870.; Подопригора ГИ, Кафарская ЛИ, Байнов НА, Шкопоров АН. Бактериальная транслокация из кишечника: микробиологические, иммунологические и патофизиологические аспекты. Вестник Российской академии меди­ цинских наук. 2015;(6):640–650. https://doi.org/10.15690/vramn564.; Nelson DB. Infectious disease complications of GI endoscopy: part II, exogenous infections. Gastrointest Endosc. 2003;57(6):695–711. https://doi.org/10.1067/mge.2003.202.; Khashab MA, Chithadi KV, Acosta RD, Bruining DH, Chandrasekhara V, Eloubeidi MA et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2015;81(1):81–89. https://doi.org/10.1016/j.gie.2014.08.008.; Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med. 2007;147(12):829–835. https://doi.org/10.7326/0003-4819-147-12-200712180-00002.; Akuzawa N, Kurabayashi M. Native valve endocarditis due to Escherichia coli infection: a case report and review of the literature. BMC Cardiovasc Disord. 2018;18(1):195. https://doi.org/10.1186/s12872-018-0929-7.; Watanakunakorn C, Burkert T. Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes. Medicine (Baltimore). 1993;72(2):90–102. https://doi.org/10.1097/00005792-199303000-00003.; Kim CJ, Yi JE, Kim Y, Choi HJ. Emphysematous endocarditis caused by AmpC beta-lactamase-producing Escherichia coli: A case report. Medicine (Baltimore). 2018;97(6):e9620. https://doi.org/10.1097/MD.0000000000009620.; Tsutsumi T, Hiraoka E, Kanazawa K, Akita H, Eron LJ. Diagnosis of E. coli tricuspid valve endocarditis: a case report. Hawaii Med J. 2010;69(12):286. Available at: https://pubmed.ncbi.nlm.nih.gov/21225584.; Spaleniak S, Romejko-Ciepielewska K, Lubas A, Ryczek R, Niemczyk S. Infective endocarditis in the course of urosepsis E. coli ESBL(+) in a patient with Goodpasture’s syndrome. Kardiol Pol. 2015;73(8):670. https://doi.org/10.5603/KP.2015.0154.; Nikolich-Žugich J. Author Correction: The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018;19(10):1146. https://doi.org/10.1038/s41590-018-0205-0.; Tamura J, Kubota K, Murakami H, Sawamura M, Matsushima T, Tamura T, Saitoh T, Kurabayshi H, Naruse T. Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clin Exp Immunol. 1999;116(1):28–32. https://doi.org/10.1046/j.1365-2249.1999.00870.x.; Yumoto T, Kono Y, Kawano S, Kamoi C, Iida A, Nose M et al. Citrobacter braakii bacteremia-induced septic shock after colonoscopy preparation with polyethylene glycol in a critically ill patient: a case report. Ann Clin Microbiol Antimicrob. 2017;16(1):22. https://doi.org/10.1186/s12941-017-0201-5.; Darrow CJ, Devito JF. An occurrence of sepsis during inpatient fecal disimpaction. Pediatrics. 2014;133(1):e235–239. https://doi.org/10.1542/peds.2012-2963.; Cullender TC, Chassaing B, Janzon A, Kumar K, Muller CE, Werner JJ et al. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cell Host Microbe. 2013;14(5):571–581. https://doi.org/10.1016/j.chom.2013.10.009.; Barbara G, Scaioli E, Barbaro MR, Biagi E, Laghi L, Cremon C et al. Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease. Gut. 2017;66(7):1252–1261. https://doi.org/10.1136/gutjnl-2016-312377.; Nagata N, Tohya M, Fukuda S, Suda W, Nishijims A, Takeuchi F et al. Effects of bowel preparation on the human gut microbiome and metabolome. Sci Rep. 2019;9(1):4042. https://doi.org/10.1038/s41598-019-40182-9.; Drago L, Toscano M, De Grandi R, Casini V, Pace F. Persisting changes of intestinal microbiota after bowel lavage and colonoscopy. Eur J Gastroenterol Hepatol. 2016;28(5):532–537. https://doi.org/10.1097/MEG.0000000000000581.; Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, Wekerle H, Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538–541. https://doi.org/10.1038/nature10554.; https://www.med-sovet.pro/jour/article/view/7859

الاتاحة: https://www.med-sovet.pro/jour/article/view/7859
https://doi.org/10.21518/ms2023-390

المؤلفون: V. P. Sereda, D. A. Svirido, M. V. Komarov, O. A. Smulskaya, В. П. Середа, Д. А. Свиридо, М. В. Комаров, О. А. Смульская

المصدر: Meditsinskiy sovet = Medical Council; № 4 (2023); 18-27 ; Медицинский Совет; № 4 (2023); 18-27 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: реальная клиническая практика, eosinophilia, monoclonal antibodies, biological therapy, benralizumab, mepolizumab, nasal polyposis, eosinophilic granulomatosis with polyangiitis, real-world clinical practice, эозинофилия, моноклональные антитела, биологическая терапия, бенрализумаб, меполизумаб, полипоз носа, эозинофильный гранулематоз с полиангиитом

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7279/6614; Авдеев С.Н., Ненашева Н.М., Жуденков К.В., Петраковская В.А., Изюмова Г.В. Распространенность, заболеваемость, фенотипы и другие характеристики тяжелой бронхиальной астмы в Российской Федерации. Пульмонология. 2018;28(3):341–358. https://doi.org/10.18093/0869-0189-2018-28-3-341-358.; Княжеская Н.П., Анаев Э.Х., Камелева А.А., Сафошкина Е.В., Кириченко Н.Д. Таргетная терапия бронхиальной астмы. Бенрализумаб: в фокусе внимания пациенты, принимающие системные глюкокортикостероиды. Медицинский совет. 2020;(17):9–16. https://doi.org/10.21518/2079-701X-2020-17-9-16.; Ray A., Raundhal M., Oriss T.B., Ray P., Wenzel S.E. Current concepts of severe asthma. J Clin Invest. 2016;126(7):2394–2403. https://doi.org/10.1172/JCI84144.; Buhl R., Humbert M., Bjermer L., Chanez P., Heaney L.G., Pavord I. et al.; Expert group of the European Consensus Meeting for Severe Eosinophilic Asthma. Severe eosinophilic asthma: a roadmap to consensus. Eur Respir J. 2017;49(5):1700634. https://doi.org/10.1183/13993003.00634-2017.; Holguin F., Cardet J.C., Chung K.F., Diver S., Ferreira D.S., Fitzpatrick A. et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2020;55(1):1900588. https://doi.org/10.1183/13993003.00588-2019.; Чучалин А.Г., Авдеев С.Н., Айсанов З.Р., Белевский А.С., Васильева О.С., Геппе Н.А. и др. Бронхиальная астма: клинические рекомендации. М.; 2021. 114 с. Режим доступа: https://cr.minzdrav.gov.ru/recomend/359.; Schleich F.N., Chevremont A., Paulus V., Henket M., Manise M., Seidel L., Louis R. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. Eur Respir J. 2014;44(1):97–108. https://doi.org/10.1183/09031936.00201813.; Agache I., Beltran J., Akdis C., Akdis M., Canelo-Aybar C., Canonica G.W. et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines – recommendations on the use of biologicals in severe asthma. Allergy. 2020;75(5):1023–1042. https://doi.org/10.1111/all.14221.; Ненашева Н.М., Курбачева О.М., Авдеев С.Н., Федосенко С.В., Емельянов А.В., Белевский А.С. и др. Практические рекомендации по выбору иммунобиологического препарата для лечения тяжелой бронхиальной астмы Т2-эндотипа. Пульмонология. 2020;30(2):227–244. https://doi.org/10.18093/0869-0189-2020-30-2-227-244.; Dahlén S.E. Asthma phenotyping: noninvasive biomarkers suitable for bedside science are the next step to implement precision medicine. J Intern Med. 2016;279(2):205–207. https://doi.org/10.1111/joim.12466.; Bleecker E.R., FitzGerald J.M., Chanez P., Papi A., Weinstein S.F., Barker P. et al. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet. 2016;388(10056):2115–2127. https://doi.org/10.1016/S0140-6736(16)31324-1.; FitzGerald J.M., Bleecker E.R., Nair P., Korn S., Ohta K., Lommatzsch M. et al.; CALIMA study investigators. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2016;388(10056):2128–2141. https://doi.org/10.1016/S0140-6736(16)31322-8.; Sehmi R., Lim H.F., Mukherjee M., Huang C., Radford K., Newbold P. et al. Benralizumab attenuates airway eosinophilia in prednisone-dependent asthma. J Allergy Clin Immunol. 2018;141(4):1529–1532.e8. https://doi.org/10.1016/j.jaci.2018.01.008.; FitzGerald J.M., Bleecker E.R., Menzies-Gow A., Zangrilli J.G., Hirsch I., Metcalfe P. et al. Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies. Lancet Respir Med. 2018;6(1):51–64. https://doi.org/10.1016/S2213-2600(17)30344-2.; Bachert C., Han J.K., Desrosiers M.Y., Gevaert P., Heffler E., Hopkins C. et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial. J Allergy Clin Immunol. 2022;149(4):1309–1317.e12. https://doi.org/10.1016/j.jaci.2021.08.030.; Korn S., Bourdin A., Chupp G., Cosio B.G., Arbetter D., Shah M., Gil E.G. Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years. J Allergy Clin Immunol Pract. 2021;9(12):4381–4392.e4. https://doi.org/10.1016/j.jaip.2021.07.058.; Menzies-Gow A., Gurnell M., Heaney L.G., Corren J., Bel E.H., Maspero J. et al. Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study. Lancet Respir Med. 2022;10(1):47–58. https://doi.org/10.1016/S2213-2600(21)00352-0.; Chung Y., Katial R., Mu F., Cook E.E., Young J., Yang D. et al. Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study. Ann Allergy Asthma Immunol. 2022;128(6):669–676.e6. https://doi.org/10.1016/j.anai.2022.02.017.; Pelaia C., Busceti M.T., Vatrella A., Rago G.F., Crimi C., Terracciano R., Pelaia G. Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose. Pulm Pharmacol Ther. 2019;58:101830. https://doi.org/10.1016/j.pupt.2019.101830.; Kavanagh J.E., Hearn A.P., Dhariwal J., d’Ancona G., Douiri A., Roxas C. et al. Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma. Chest. 2021;159(2):496–506. https://doi.org/10.1016/j.chest.2020.08.2083.; Nair P., Wenzel S., Rabe K.F., Bourdin A., Lugogo N.L., Kuna P. et al. Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma. N Engl J Med. 2017;376(25):2448–2458. https://doi.org/10.1056/NEJMoa1703501.; Бекетова Т.В., Попов И.Ю., Бабак В.В. Обзор рекомендаций по лечению АНЦА-ассоциированных системных васкулитов, представленных в 2021 г. Американской коллегией ревматологов и Фондом васкулитов. Научно-практическая ревматология. 2021;59(6):684–692. https://doi.org/10.47360/1995-4484-2021-684-692.; Lugogo N., Domingo C., Chanez P., Leigh R., Gilson M.J., Price R.G. et al. Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study. Clin Ther. 2016;38(9):2058–2070.e1. https://doi.org/10.1016/j.clinthera.2016.07.010.; Wechsler M.E., Akuthota P., Jayne D., Khoury P., Klion A., Langford C.A. et al. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med. 2017;376(20):1921–1932. https://doi.org/10.1056/NEJMoa1702079.; Menzella F., Galeone C., Ghidoni G., Ruggiero P., Capobelli S., Simonazzi A. et al. Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab. Multidiscip Respir Med. 2021;16(1):779. https://doi.org/10.4081/mrm.2021.779.; https://www.med-sovet.pro/jour/article/view/7279

الاتاحة: https://www.med-sovet.pro/jour/article/view/7279
https://doi.org/10.21518/ms2022-004

المؤلفون: G. L. Ignatova, A. Yu. Petukhova, L. N. Novikova, V. P. Sereda, N. V. Teplova, O. A. Mubarakshina, Г. Л. Игнатова, А. Ю. Петухова, Л. Н. Новикова, В. П. Середа, Н. В. Теплова, О. А. Мубаракшина

المصدر: PULMONOLOGIYA; Том 32, № 5 (2022); 774-781 ; Пульмонология; Том 32, № 5 (2022); 774-781 ; 2541-9617 ; 0869-0189

وصف الملف: application/pdf

Relation: https://journal.pulmonology.ru/pulm/article/view/4167/3454; Donnelly J.P., Wang X.Q., Iwashyna T.J. et al. Readmission and death after initial hospital discharge among patients with COVID-19 in a large multihospital system. JAMA. 2021; 325 (3): 304–306. DOI:10.1001/jama.2020.21465.; Ambardar S.R. Hightower S.L., Huprikar N.A. et al. Post-COVID-19 pulmonary fibrosis: novel sequelae of the current pandemic. J. Clin. Med. 20221; 10 (11): 2452. DOI:10.3390/jcm10112452.; Antoniou K.M., Vasarmidi E., Russell A.-M. et al. European Respiratory Society statement on long COVID-19 follow-up. Eur. Respir. J. 2022; in press. DOI:10.1183/13993003.02174-2021.; Funke-Chamboura M., Bridevaux P.-O., Clarenbache C.F. et al. Swiss recommendations for the follow-up and treatment of pulmonary long COVID. Respiration. 2021; 100 (8): 826–841. DOI:10.1159/000517255.; Kaber G., Kratochvil M.J., Burgener E.B. et al. Hyaluronan is abundant in COVID-19 respiratory secretions. medRxiv Preprint. 2020; Sept. 11. DOI:10.1101/2020.09.11.20191692.; Osmanov I.M., Spiridonova E., Bobkova P. et al. Risk factors for long COVID in previously hospitalised children using the ISARIC global follow-up protocol: a prospective cohort study. Eur. Respir. J. 2021; July 1: 2101341. DOI:10.1183/13993003.01341-2021. Epub ahead of print. PMID: 34210789.; https://journal.pulmonology.ru/pulm/article/view/4167

الاتاحة: https://journal.pulmonology.ru/pulm/article/view/4167
https://doi.org/10.18093/0869-0189-2022-32-5-774-781

المؤلفون: V. P. Sereda, D. A. Svirido, M. V. Komarov, Zhanna A Mironova, M. A. Nyoma, В. П. Середа, Д. А. Свиридо, М. В. Комаров, Ж. А. Миронова, М. А. Нёма

المساهمون: нет

المصدر: PULMONOLOGIYA; Том 32, № 5 (2022); 670-677 ; Пульмонология; Том 32, № 5 (2022); 670-677 ; 2541-9617 ; 0869-0189

مصطلحات موضوعية: реальная клиническая практика, asthma control, eosinophilia, monoclonal antibodies, biological therapy, benralizumab, nasal polyposis, realworld clinical practice, контроль над бронхиальной астмой, эозинофилия, моноклональные антитела, биологическая терапия, бенрализумаб, полипоз носа

وصف الملف: application/pdf

Relation: https://journal.pulmonology.ru/pulm/article/view/4129/3440; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1490; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1497; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1498; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1499; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1500; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1501; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1502; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1503; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1504; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1507; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1508; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1510; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1511; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1512; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1513; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1514; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1515; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1516; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1517; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1518; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1519; https://journal.pulmonology.ru/pulm/article/downloadSuppFile/4129/1523; Авдеев С.Н., Ненашева Н.М., Жуденков К.В. и др. Распространенность, заболеваемость, фенотипы и другие характеристики тяжелой бронхиальной астмы в Российской Федерации. Пульмонология. 2018; 28 (3): 341–358. DOI:10.18093/0869-0189-2018-28-3-341-358.; Княжеская Н.П., Анаев Э.Х., Камелева А.А. и др. Таргетная терапия бронхиальной астмы. Бенрализумаб: в фокусе внимания пациенты, принимающие системные глюкокортикостероиды. Медицинский Совет. 2020; (17): 9–16. DOI:10.21518/2079-701X2020-17-9-16.; Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2022 Report. Available at: https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL22-07-01-WMS.pdf [Accessed: May 17, 2022].; Ненашева Н.М., Курбачева О.М., Авдеев С.Н. и др. Практические рекомендации по выбору иммунобиологического препарата для лечения тяжелой бронхиальной астмы Т2-эндотипа. Пульмонология. 2020; 30 (2): 227–244. DOI:10.18093/0869-0189-2020-30-2-227-244.; Инструкция по медицинскому применению лекарственного препарата Фазенра. Доступно на: https://www.astrazeneca.ru/content/dam/az-ru/downloads/preparations/Fasenra-Pen-Leaflet-RU-V1.pdf; Bleecker E.R., FitzGerald J.M., Chanez P. et al. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2 -agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet. 2016; 388 (10056): 2115–2127. DOI:10.1016/S0140-6736(16)31324-1.; FitzGerald J.M., Bleecker E.R., Nair P. et al. Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2016; 388 (10056): 2128–2141. DOI:10.1016/S0140-6736(16)31322-8.; Bachert C., Han J.K., Desrosiers M.Y. et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2022; 149 (4): 1309–1317.e12. DOI:10.1016/j.jaci.2021.08.030.; Korn S., Bourdin A., Chupp G. et al. Integrated safety and efficacy among patients receiving benralizumab for up to 5 years. J. Allergy Clin. Immunol. Pract. 2021; 9 (12): 4381–4392.e4. DOI:10.1016/j.jaip.2021.07.058.; Menzies-Gow A., Gurnell M., Heaney L.G. et al. Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study. Lancet Respir. Med. 2022; 10 (1): 47–58. DOI:10.1016/S2213-2600(21)00352-0.; Chung Y., Katial R., Mu F. et al. Real-world effectiveness of benralizumab: results from the ZEPHYR 1 study. Ann. Allergy Asthma Immunol. 2022; 128 (6): 669–676.e6. DOI:10.1016/j.anai.2022.02.017.; Pelaia C., Busceti M.T., Vatrella A. et al. Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose. Pulm. Pharmacol. Ther. 2019; 58: 101830. DOI:10.1016/j.pupt.2019.101830.; Kavanagh J.E., Hearn A.P., Dhariwal J. et al. Real-world effectiveness of benralizumab in severe eosinophilic asthma. Chest. 2021; 159 (2): 496–506. DOI:10.1016/j.chest.2020.08.2083.; Nair P., Wenzel S., Rabe K.F. et al. Oral glucocorticoid-sparing effect of benralizumab in severe asthma. N. Engl. J. Med. 2017; 376 (25): 2448–2458. DOI:10.1056/NEJMoa1703501.; https://journal.pulmonology.ru/pulm/article/view/4129

الاتاحة: https://journal.pulmonology.ru/pulm/article/view/4129
https://doi.org/10.18093/0869-0189-2022-32-5-670-677

المؤلفون: L. L. Bobrov, A. G. Obrezan, V. P. Sereda, Л. Л. Бобров, А. Г. Обрезан, В. П. Середа

المصدر: PULMONOLOGIYA; № 2 (2003); 48-52 ; Пульмонология; № 2 (2003); 48-52 ; 2541-9617 ; 0869-0189

وصف الملف: application/pdf

Relation: https://journal.pulmonology.ru/pulm/article/view/2740/2161; Бронхиальная астма. Глобальная стратегия: Совместный доклад Национального института Сердце, Легкие, Кровь и Всемирной организации здравоохранения: Пер. с англ. Пульмонология 1996; Прил.: 1-165.; Енисеева Е.С., Сизых Т.П. Состояние гемодинамики и диастолическая функция правого желудочка у больных бронхиальной астмой. Тер. арх. 1995; 67 (8): 39-42.; Мухарлямов Н.М. Легочное сердце. М.: Медицина; 1973.; Павлищук С.А., Кокарев Ю.С., Лушпай Т.Ю., Мохммед Аль-Фарра Риад. Насосная функция ЛЖ на этапах формиро­; вания легочного сердца. Кардиология 1990; 30 (9): 64-67.; Палеев Н.Р., Царькова Л.Н., Чирейская И.К. Легочные гипертензии при заболеваниях легких. В кн.: Палеев Н.Р. (ред.); Болезни органов дыхания. М.: Медицина; 1990; т.З: 245-290.; Перлей В.Е. Функция правых отделов сердца и развития правожелудочковой недостаточности у больных хроническими не­; специфическими заболеваниями легких: Автореф. дис. . д-ра мед. наук. СПб; 1995.; Aoki T., Iwase М., Watanabe T. et al. Left ventricular function in asthmatic children chronically treaied with theophylline evaluated by exercise Doppler echocardiography. Int. J. Card: Imag. 1994; 10 (4): 299-304.; Ferlinz J. Right ventricular diastolic performance: compliance characteristics with focus on pulmonary hypertension, right ventricular hypertrophy, and calcium channel blockade. Cathet. Cardiovasc. Diagn. 1998; 43 (2): 206-243.; Giangrasso T. Potential for tolerance, morbidity, and mortality resulting from regular use of beta 2-adrenergic agonists in asthma. South. Med. J. 1997; 90 (2): 173-179.; International consensus report on diagnosis and management of asthma (National Heart, Lung and Blood Institute, National Institutes of Health). Eur. Respir. J. 1992; 5 (5): 601-641.; Lanes S.F., Birmann B., Raiford D., Walker A.M. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992. J. Clin. Epidemiol. 1997; 50 (3): 321-328.; Marrone O., Bellia V., Ferrara G. Transmural pressure measurement. Importance in the assessment of pulmonary hypertension in obstructive sleep apneas. Chest 1989; 95 (2): 338-342.; Nagaya N., Satoh T., Uematsu M. et al. Shortening of Doppler-derived deceleration time of early diastolic transmitral flow in the presence of pulmonary hypertension through ventricular interaction. Am. J. Cardiol. 1997; 79 (11): 1502-1506.; Santamore W.P., Dell'Italia L.J. Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function. Progr. Cardiovasc. Dis. 1998; 40 (4): 289-308.; Schulman D.S., Biondi J.W., Zohgbi S. et al. Left ventricular diastolic function during positive end-expiratory pressure. Impact of right ventricular ischemia and ventricular interaction. Am. Rev. Respir. Dis. 1992; 145 (3): 515-521.; https://journal.pulmonology.ru/pulm/article/view/2740

الاتاحة: https://journal.pulmonology.ru/pulm/article/view/2740

المؤلفون: V. P. Sereda, A. S. Svistov, В. П. Середа, А. С. Свистов

المصدر: PULMONOLOGIYA; № 2 (2005); 66-72 ; Пульмонология; № 2 (2005); 66-72 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2005-0-2

وصف الملف: application/pdf

Relation: https://journal.pulmonology.ru/pulm/article/view/2052/1649; Чучалин А.Г. (ред.). Глобальная стратегия лечения и профилактики бронхиальной астмы. М.: Атмосфера; 2002.; Rodrigo G., Rodrigo C. Corticosteroids in the emergency department therapy of acute adult asthma: an evidence based evaluation. Chest. 1999; 116 (2): 285–295.; Цой А.Н. Применение глюкокортикостероидов в лечении хронических обструктивных болезней легких. В кн.: Чучалин А.Г. (ред.). Хронические обструктивные болезни легких. М.: БИНОМ; 1999. 445–461.; Edmonds M.L., Camargo C.A. Jr., Pollack C.V. Jr., Rowe B.H. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. (Cochrane Review). Cochrane Library 2003; Iss. 2: ab002308–20021.; Чучалин А.Г. Тяжелая бронхиальная астма. Рус. мед. журн. 2000; 8 (12): 482–486.; Цой А.Н., Аржакова Л.С., Архипов В.В. Фармакодинамика и клиническая эффективность ингаляционных глюкокортикостероидов у больных с обострением бронхиальной астмы. Пульмонология 2002; 12 (3): 88–92.; Gibson P.G., Saltos N., Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 2001; 163 (1): 32–36.; Геппе Н.А. Место будесонида (Пульмикорта) суспензии для небулайзера в терапии бронхиальной астмы у детей. Клин. фармакол. и терапия. 1999; 8 (5): 40–43.; Shapiro G., Mendelson L., Kraemer M.J. et al. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid dependent, persistent asthma. J. Allergy Clin. Immunol. 1998; 102 (5): 789–796.; Wales D., Makker H., Kane J. et al. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers. Chest 1999; 115 (5): 1278–1284.; Devidayal S.S., Kumar L., Jayshree M. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr. 1999; 88 (8): 835–840.; Sung L., Osmond M.H., Klassen T.P. Randomized, controlled trial of inhaled budesonide as an adjunct to oral prednisone in acute asthma. Acad. Emerg. Med. 1998; 5 (3): 209–213.; Авдеев С.Н. Ингаляционный будесонид (суспензия Пульмикорта) при бронхиальной астме. Атмосфера. Пульмонол. и аллергол. 2002; 3 (6): 31–34.; Передельская О.А. Оценка эффективности и безопасности небулайзерной терапии бронхолитиками и суспензией пульмикорта при лечении тяжелого обострения бронхиальной астмы: Автореф. дис. . канд. мед. наук. М.; 2002.; Mitchell C.E., Alpers J.H., Morton S.M. et al. Comparison of nebulized budesonide with oral prednisolone in the treatment of severe acute asthma (abstract). Eur. Respir. J. 1995; 8 (suppl. 19): 490s.; Hendeles L., Sherman J. Are inhaled corticosteroids effective for acute exacerbations of asthma in children? J. Pediatr. 2003; 142 (suppl. 2): S26–S32.; https://journal.pulmonology.ru/pulm/article/view/2052

الاتاحة: https://journal.pulmonology.ru/pulm/article/view/2052
https://doi.org/10.18093/0869-0189-2005-0-2-66-72

المؤلفون: V. P. Sereda, T. S. Panasyuk, V. I. Kushch, O. N. Kaidash, Sergey Dub

المصدر: Journal of Superhard Materials. 37:8-13

مصطلحات موضوعية: Inorganic Chemistry, chemistry.chemical_compound, Materials science, chemistry, Homogeneous, Nucleation, General Materials Science, Penetration (firestop), Boron carbide, Plasticity, Composite material, Nanoindentation, Dislocation

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::70691a942c754f93391ea397ecbfd126
https://doi.org/10.3103/s1063457615010025

المؤلفون: V P, Sereda, A S, Svistov

المصدر: Klinicheskaia meditsina. 83(12)

مصطلحات موضوعية: Adult, Male, Inpatients, Anti-Inflammatory Agents, Middle Aged, Patient Readmission, Severity of Illness Index, Asthma, Treatment Refusal, Patient Admission, Patient Education as Topic, Acute Disease, Administration, Inhalation, Humans, Female, Anti-Asthmatic Agents, Glucocorticoids, Aged, Retrospective Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::dd7a8633a642551c17ebcd0edda58b3d
https://pubmed.ncbi.nlm.nih.gov/16502722

المؤلفون: V P, Sereda, A S, Svistov

المصدر: Klinicheskaia meditsina. 82(6)

مصطلحات موضوعية: Adult, Male, Nebulizers and Vaporizers, Administration, Inhalation, Humans, Female, Middle Aged, Budesonide, Severity of Illness Index, Asthma, Bronchodilator Agents

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::5417e206b35f8a28c515a319adb51375
https://pubmed.ncbi.nlm.nih.gov/15344695

المؤلفون: G N, Ponomarenko, E V, Ponomareva, V P, Sereda

المصدر: Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury. (5)

مصطلحات موضوعية: Adult, Air Ionization, Male, Respiratory Therapy, Treatment Outcome, Adolescent, Humans, Female, Middle Aged, Severity of Illness Index, Asthma, Aged, Respiratory Function Tests

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::115830d13ad698548a997b3b6b0a15c8
https://pubmed.ncbi.nlm.nih.gov/14650127

المؤلفون: L L, Bobrov, A G, Obrezan, V P, Sereda

المصدر: Klinicheskaia meditsina. 81(5)

مصطلحات موضوعية: Adult, Male, Ventricular Dysfunction, Left, Spirometry, Hemodynamics, Humans, Female, Lung Diseases, Obstructive, Severity of Illness Index, Asthma

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::0b9f22cc385cda8947629a775cbd4a72
https://pubmed.ncbi.nlm.nih.gov/12856567

المؤلفون: L L, Bobrov, G N, Ponomarenko, V P, Sereda

المصدر: Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury. (1)

مصطلحات موضوعية: Adult, Aerosols, Male, Adolescent, Microclimate, Middle Aged, Sodium Chloride, Environment, Controlled, Combined Modality Therapy, Asthma, Administration, Inhalation, Chronic Disease, Humans, Female, Physical Therapy Modalities, Aged

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::879ed7be96684486fc2519b25f6efe9f
https://pubmed.ncbi.nlm.nih.gov/11094876

المؤلفون: L L, Bobrov, G N, Ponomarenko, V P, Sereda, A V, Chervinskaia

المصدر: Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury. (4)

مصطلحات موضوعية: Adult, Aerosols, Male, Adolescent, Sputum, Middle Aged, Sodium Chloride, Combined Modality Therapy, Asthma, Bronchial Provocation Tests, Chronic Disease, Humans, Female, Anti-Asthmatic Agents, Aged

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::349d754f1bfe8b2f9acf74048ce958b4
https://pubmed.ncbi.nlm.nih.gov/10513463

المؤلفون: V V, Ivashchenko, V S, Koval'chuk, A T, Tikhiĭ, V P, Sereda, A P, Mel'nik

المصدر: Klinichna khirurhiia. (9-10)

مصطلحات موضوعية: Adult, Male, Reoperation, Ileocecal Valve, Cholelithiasis, Ileal Diseases, Acute Disease, Humans, Female, Jejunal Diseases, Middle Aged, Intestinal Obstruction, Aged

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::f9ee41b352890c79b18da8e8a7af24b1
https://pubmed.ncbi.nlm.nih.gov/10050379